115 related articles for article (PubMed ID: 6264377)
1. Effect of parathyroid hormone on vitamin D metabolism in osteopetrosis.
Aarskog D; Aksnes L; Markestad T
Pediatrics; 1981 Jul; 68(1):109-12. PubMed ID: 6264377
[TBL] [Abstract][Full Text] [Related]
2. Acute response of parathyroid hormone in congenital osteopetrosis.
Aarskog D; Asknes L; Haneberg B; Julshamn K
Acta Paediatr Scand Suppl; 1979; 277():75-80. PubMed ID: 232356
[TBL] [Abstract][Full Text] [Related]
3. Hypo-hyperparathyroidism: evidence for a defective parathyroid hormone.
Connors MH; Irias JJ; Golabi M
Pediatrics; 1977 Sep; 60(3):343-8. PubMed ID: 197477
[TBL] [Abstract][Full Text] [Related]
4. [Abnormal synthesis of 1,25-dihydroxyvitamin D and hypercalcemia in children with tuberculosis].
Saggese G; Bertelloni S; Baroncelli GI; Fusaro C; Gualtieri M
Pediatr Med Chir; 1989; 11(5):529-32. PubMed ID: 2631059
[TBL] [Abstract][Full Text] [Related]
5. Serum calcium, parathyroid hormone, and urinary cyclic adenosine monophosphate after parathyroidectomy.
Kaplan EL; Fang VS; Sugimoto J; Fredland A
Surgery; 1982 Nov; 92(5):822-6. PubMed ID: 6291182
[TBL] [Abstract][Full Text] [Related]
6. Effect of short-term hyperthyroxinemia on vitamin D metabolism in congenital hypothyroidism.
Laufer J; Noff D; Orda S; Sack J
Horm Metab Res; 1993 Jul; 25(7):386-8. PubMed ID: 8406326
[TBL] [Abstract][Full Text] [Related]
7. Effects of parathyroid hormone and calcitonin on plasma and nephrogenous cyclic adenosine-3',5'-monophosphate in normal subjects and in pathological conditions.
Caniggia A; Gennari C; Lore F; Nuti R; Galli M
Eur J Clin Invest; 1980 Apr; 10(2 Pt 1):99-105. PubMed ID: 6257524
[TBL] [Abstract][Full Text] [Related]
8. Linear growth in relation to the circulating concentrations of insulin-like growth factor I, parathyroid hormone, and 25-hydroxy vitamin D in children with nutritional rickets before and after treatment: endocrine adaptation to vitamin D deficiency.
Soliman AT; Al Khalaf F; Alhemaidi N; Al Ali M; Al Zyoud M; Yakoot K
Metabolism; 2008 Jan; 57(1):95-102. PubMed ID: 18078865
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D physiology.
Lips P
Prog Biophys Mol Biol; 2006 Sep; 92(1):4-8. PubMed ID: 16563471
[TBL] [Abstract][Full Text] [Related]
10. Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols.
Salusky IB; Goodman WG; Sahney S; Gales B; Perilloux A; Wang HJ; Elashoff RM; Jüppner H
J Am Soc Nephrol; 2005 Aug; 16(8):2501-8. PubMed ID: 15944337
[TBL] [Abstract][Full Text] [Related]
11. [Investigations of the urinary cAMP-excretion in pseudohypoparathyroidism (author's transl)].
Stögmann W
Padiatr Padol Suppl; 1977; (5):63-9. PubMed ID: 199875
[TBL] [Abstract][Full Text] [Related]
12. [The effect of unilateral nephrectomy on vitamin D metabolism in pregnant rats].
Ivashkevich SP; Shirankova TG; Apukhovskaia LI; Omel'chenko LI
Vopr Med Khim; 1992; 38(5):44-7. PubMed ID: 1492397
[TBL] [Abstract][Full Text] [Related]
13. Effect of parathyroid hormone on cAMP and 1,25-dihydroxyvitamin D formation and renal handling of phosphate in vitamin D-dependent rickets.
Aarskog D; Aksnes L; Markestad T
Pediatrics; 1983 Jan; 71(1):59-63. PubMed ID: 6294581
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D and parathyroid hormone status in children with the nephrotic syndrome and chronic mild glomerulonephritis.
Chesney RW; Hamstra A; Rose P; DeLuca HF
Int J Pediatr Nephrol; 1984 Mar; 5(1):1-4. PubMed ID: 6715110
[TBL] [Abstract][Full Text] [Related]
15. Reelevation of parathyroid hormone level after parathyroidectomy in patients with primary hyperparathyroidism: importance of decreased renal parathyroid hormone sensitivity.
Yamashita H; Noguchi S; Moriyama T; Takamatsu Y; Sadanaga K; Uchino S; Watanabe S; Ogawa T
Surgery; 2005 Apr; 137(4):419-25. PubMed ID: 15800489
[TBL] [Abstract][Full Text] [Related]
16. The effect of high level CaCi2 injection on parathyroid hormone dependent cAMP in stone formation patients.
Dunzendorfer U; Schmidt-Gayk H
Endokrinologie; 1982 Jun; 79(2):252-8. PubMed ID: 6290208
[TBL] [Abstract][Full Text] [Related]
17. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid function and vitamin D metabolism during human growth hormone replacement.
Gertner JM; Horst RL; Broadus AE; Rasmussen H; Genel M
J Clin Endocrinol Metab; 1979 Aug; 49(2):185-8. PubMed ID: 457839
[TBL] [Abstract][Full Text] [Related]
19. Effect of growth hormone administration: reciprocal changes in serum 1 alpha,25-dihydroxyvitamin D and intestinal calcium absorption.
Chipman JJ; Zerwekh J; Nicar M; Marks J; Pak CY
J Clin Endocrinol Metab; 1980 Aug; 51(2):321-4. PubMed ID: 6249837
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease.
Fisher L; Fisher A
Clin Gastroenterol Hepatol; 2007 Apr; 5(4):513-20. PubMed ID: 17222588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
